Journey Medical Corp
DERMNasdaqCIK 1867066HealthcareFiscal year ends Dec 31
Reports and events: 78 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1220:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094948 |
| 2026-08-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094862 |
| 2026-06-2600:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-077888 |
| 2026-05-1320:33 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-060297 |
| 2026-05-1320:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060232 |
| 2026-04-3020:06 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001104659-26-052883 |
| 2026-04-2121:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-046158 |
| 2026-03-2621:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-034629 |
| 2026-03-2520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034506 |
| 2025-11-1221:41 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110457 |
| 2025-11-1221:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110344 |
| 2025-09-2620:39 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-25-093891 |
| 2025-08-2821:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-084879 |
| 2025-08-1220:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001410578-25-001703 |
| 2025-08-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076825 |
| 2025-07-1420:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067767 |
| 2025-06-2620:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-063032 |
| 2025-06-2412:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061956 |
| 2025-05-1510:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001296 |
| 2025-05-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048502 |
| 2025-04-2920:06 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001104659-25-041214 |
| 2025-04-0311:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-031463 |
| 2025-03-2701:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001410578-25-000490 |
| 2025-03-2620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-028226 |
| 2025-03-2412:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-026878 |
| 2025-02-0521:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-009641 |
| 2024-11-1221:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001410578-24-001877 |
| 2024-11-1221:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116762 |
| 2024-11-0412:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-113659 |
| 2024-08-1322:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001410578-24-001326 |
| 2024-08-1220:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-088345 |
| 2024-07-1221:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors | 0001104659-24-079596 |
| 2024-06-2520:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-074743 |
| 2024-05-1420:46 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001410578-24-000817 |
| 2024-05-1320:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060513 |
| 2024-05-0120:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-055725 |
| 2024-04-2920:06 ET | DEF 14A | Proxy statementPeriod 2024-06-25 | 0001104659-24-054010 |
| 2024-03-2901:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001410578-24-000347 |
| 2024-03-2120:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-037318 |
| 2024-01-0221:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-000325 |
| 2023-12-0822:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-124742 |
| 2023-11-1300:55 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001410578-23-002335 |
| 2023-11-0721:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115285 |
| 2023-09-2613:10 ET | 8-K | 8.01 Other events | 0001104659-23-103747 |
| 2023-09-1920:59 ET | 8-K | 8.01 Other events | 0001104659-23-101975 |
| 2023-09-0612:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-098505 |
| 2023-08-1821:00 ET | 8-K | 3.01 Delisting notice | 0001104659-23-093537 |
| 2023-08-1020:45 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001410578-23-001702 |
| 2023-08-0820:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-088823 |
| 2023-07-2612:30 ET | 8-K | 8.01 Other events | 0001104659-23-084082 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.